Search - tctmd.com

Displaying 101 - 115 of 115

Sort: Relevancy | Date

Presentation

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Presenter: Pieter C. Smits

July 29, 2015

Presentation

Event Rates in RCTs Evaluating Cardiovascular Interventions and Devices

Presenter: KD. Mahmoud

June 09, 2015

Presentation

The HEART Pathway RCT: Identifying ED Patients with Acute Chest Pain for Early Discharge

Presenter: Simon A. Mahler

March 04, 2015

Presentation

RCT of a Dedicated Bifurcation Stent vs Provisional Stenting for Coronary Bifurcation Lesions

Presenter: P. G?n?reux

February 11, 2015

Presentation

Conflicting Results Between RCTs and Observational Studies on the Impact of PPIs on Cardiovascular Events When Coadministered With DAPT

Presenter: Chiara Melloni

January 25, 2015

Presentation

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

Presenter: G. El-Hayek

May 19, 2014

Presentation CIT 2014

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Presenter: Gao Runlin

March 22, 2014

Presentation CTO 2014

Update from the Euro CTO Registry/RCT

Presenter: Alfredo R. Galassi

February 27, 2014

Presentation

Preliminary Results from PATENT-C: A RCT Comparing A Paclitaxel-Coated Scoring Balloon to a Standard Balloon in Coronary ISR

Presenter: Gary Gershony

December 01, 2013

Presentation TCT 2013

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Presenter: E. Murat Tuzcu

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

Presenter: Jeffrey Popma

October 30, 2013

Presentation ACC 2013

One Year Outcomes and Resource Utilization in ACRIN PA 4005:Multicenter RCT of Rapid Rule-Out Strategy of CCTA vs Traditional Care

Presenter: Judd E. Hollander

March 09, 2013

Presentation TCT 2013

The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes

Presenter: Ted Feldman, Elyse Foster, Mansoor Qureshi, Brian Whisenant, John Williams, Donald Glower, Laura Mauri

January 31, 2013

Presentation

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Presenter: S. Friedland

March 06, 2012

Advertisement

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Event Rates in RCTs Evaluating Cardiovascular Interventions and Devices

The HEART Pathway RCT: Identifying ED Patients with Acute Chest Pain for Early Discharge

RCT of a Dedicated Bifurcation Stent vs Provisional Stenting for Coronary Bifurcation Lesions

Conflicting Results Between RCTs and Observational Studies on the Impact of PPIs on Cardiovascular Events When Coadministered With DAPT

Meta-analysis of RCTs Comparing Short-term vs Long-term DAPT following DES

XIENCE V China RCT 2 Year Results:A Prospective, Multi-center Randomized Trial Assessing the Safety and Effectiveness of XIENCE V Everolimus-Eluting Stent Compared to CYPHER Sirolimus-Eluting Stent

Update from the Euro CTO Registry/RCT

Preliminary Results from PATENT-C: A RCT Comparing A Paclitaxel-Coated Scoring Balloon to a Standard Balloon in Coronary ISR

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

One Year Outcomes and Resource Utilization in ACRIN PA 4005:Multicenter RCT of Rapid Rule-Out Strategy of CCTA vs Traditional Care

The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes

Meta-Analysis of RCTs on Effect of Cilostazol on Restenosis and Outcomes After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content